secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solventum Corp (SOLV)
CIK:        0001964738
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001964738-25-000062
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solventum Q2 sales up 3.9% to $2.2B; raises FY organic growth & EPS guidance
----------------------------------------------------------------------------

- GAAP diluted EPS $0.51; adjusted diluted EPS $1.69 (+8.3% YoY).
- Organic sales +2.8%; all segments positive, led by MedSurg and HIS.
- Adjusted operating margin expanded 120 bps to 21.9%.
- FY 2025 organic sales guidance raised to +2.0%-3.0%; EPS raised to $5.80-$5.95.
- Operating cash flow $169M; free cash flow $59M in Q2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964738/000196473825000062/0001964738-25-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964738/000196473825000062/solv-20250807.htm
  HTML page:      https://secwatch.observer/filing/0001964738-25-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer